featured
Anti–TNF-α vs Tocilizumab for Treating Refractory Uveitic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network
Ophthalmology 2022 May 01;129(5)520-529, M Leclercq, A Andrillon, G Maalouf, P Sève, P Bielefeld, J Gueudry, T Sené, T Moulinet, B Rouvière, D Sène, AC Desbois, F Domont, S Touhami, C El Chamieh, P Cacoub, B Bodaghi, L Biard, D SaadounFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.